Zacks Research Cuts Earnings Estimates for Moelis & Company

Moelis & Company (NYSE:MC) – Equities research analysts at Zacks Research dropped their Q3 2025 earnings estimates for Moelis & Company in a report issued on Wednesday, January 29th. Zacks Research analyst R. Department now anticipates that the asset manager will post earnings of $0.60 per share for the quarter, down from their previous estimate of $0.61. The consensus estimate for Moelis & Company’s current full-year earnings is $1.05 per share. Zacks Research also issued estimates for Moelis & Company’s Q4 2025 earnings at $0.86 EPS and FY2025 earnings at $2.39 EPS.

Other equities analysts also recently issued research reports about the company. Keefe, Bruyette & Woods upgraded Moelis & Company from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $71.00 to $86.00 in a research note on Friday, December 20th. Morgan Stanley upgraded Moelis & Company from an “underweight” rating to an “overweight” rating and increased their price target for the stock from $66.00 to $92.00 in a research note on Monday, December 9th. UBS Group upped their price objective on shares of Moelis & Company from $54.00 to $60.00 and gave the company a “sell” rating in a report on Tuesday, October 8th. Finally, Wells Fargo & Company reduced their target price on shares of Moelis & Company from $78.00 to $77.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $70.67.

Moelis & Company Stock Up 0.6 %

MC stock opened at $78.25 on Friday. The stock’s 50 day moving average is $75.31 and its 200-day moving average is $70.37. Moelis & Company has a twelve month low of $46.24 and a twelve month high of $81.60. The firm has a market capitalization of $5.86 billion, a PE ratio of 147.64 and a beta of 1.39.

Institutional Investors Weigh In On Moelis & Company

Institutional investors have recently made changes to their positions in the company. Bank of Montreal Can boosted its position in Moelis & Company by 2.7% in the second quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager’s stock worth $409,000 after purchasing an additional 192 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Moelis & Company by 12.3% in the second quarter. The Manufacturers Life Insurance Company now owns 54,462 shares of the asset manager’s stock worth $3,097,000 after purchasing an additional 5,954 shares during the period. Algert Global LLC purchased a new stake in Moelis & Company in the 2nd quarter worth $382,000. Sanctuary Advisors LLC bought a new stake in Moelis & Company during the 2nd quarter valued at approximately $554,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Moelis & Company by 115.8% in the third quarter. GAMMA Investing LLC now owns 995 shares of the asset manager’s stock worth $68,000 after buying an additional 534 shares in the last quarter. Hedge funds and other institutional investors own 91.53% of the company’s stock.

Moelis & Company Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.